Arcus Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Arcus Biosciences, Inc.‘s stocks are currently a part of 112 hedge funds’ portfolios, which represents 38.13% of the total amount of its stocks outstanding. This makes up a total of 27.45M shares of Arcus Biosciences, Inc.. Compared to the previous quarter, the number fell by -48.93% or -26.30M shares fewer. As for the holding position changes, 38.39% (43) of current hedge fund investors increased the number of shares held, 33.93% (38) of current holders sold a part of the shares held, and 17.86% (20) closed the holdings completely. 16 hedge funds are new holders of Arcus Biosciences, Inc. stock in Q1 2023, it is 14.29% of total holders.
Hedge funds holding Arcus Biosciences (Q2 2018 – Q1 2023)
| Q2 2018 | 62 |
|---|---|
| Q3 2018 | 57 |
| Q4 2018 | 66 |
| Q1 2019 | 63 |
| Q2 2019 | 76 |
| Q3 2019 | 73 |
| Q4 2019 | 75 |
| Q1 2020 | 92 |
| Q2 2020 | 139 |
| Q3 2020 | 126 |
| Q4 2020 | 146 |
| Q1 2021 | 145 |
| Q2 2021 | 128 |
| Q3 2021 | 129 |
| Q4 2021 | 138 |
| Q1 2022 | 148 |
| Q2 2022 | 162 |
| Q3 2022 | 170 |
| Q4 2022 | 195 |
| Q1 2023 | 112 |
Hedge funds changes in Arcus Biosciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 27 | 13 | 11 | 22 | -11 |
|---|---|---|---|---|---|
| Q3 2018 | 6 | 25 | 13 | 11 | 2 |
| Q4 2018 | 19 | 27 | 13 | 10 | -3 |
| Q1 2019 | 8 | 22 | 14 | 11 | 8 |
| Q2 2019 | 18 | 26 | 12 | 3 | 17 |
| Q3 2019 | 7 | 34 | 19 | 9 | 4 |
| Q4 2019 | 11 | 34 | 15 | 9 | 6 |
| Q1 2020 | 26 | 26 | 26 | 8 | 6 |
| Q2 2020 | 59 | 48 | 24 | 12 | -4 |
| Q3 2020 | 19 | 56 | 37 | 31 | -17 |
| Q4 2020 | 37 | 41 | 50 | 17 | 1 |
| Q1 2021 | 24 | 51 | 53 | 24 | -7 |
| Q2 2021 | 14 | 45 | 46 | 31 | -8 |
| Q3 2021 | 17 | 36 | 50 | 15 | 11 |
| Q4 2021 | 29 | 48 | 48 | 20 | -7 |
| Q1 2022 | 31 | 43 | 52 | 22 | 0 |
| Q2 2022 | 50 | 62 | 30 | 34 | -14 |
| Q3 2022 | 23 | 75 | 51 | 15 | 6 |
| Q4 2022 | 48 | 67 | 61 | 20 | -1 |
| Q1 2023 | 16 | 43 | 38 | 20 | -5 |
Hedge funds changes in Arcus Biosciences stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 1,000 |
| Q4 2019 | 13,000 | 0 |
| Q1 2020 | 0 | 8,000 |
| Q2 2020 | 3,443,000 | 661,000 |
| Q3 2020 | 7,177,000 | 1,118,000 |
| Q4 2020 | 6,798,000 | 4,218,000 |
| Q1 2021 | 3,190,000 | 13,105,000 |
| Q2 2021 | 7,628,000 | 13,972,000 |
| Q3 2021 | 4,843,000 | 1,371,000 |
| Q4 2021 | 6,083,000 | 9,314,000 |
| Q1 2022 | 23,425,000 | 11,117,000 |
| Q2 2022 | 17,558,000 | 28,869,000 |
| Q3 2022 | 4,868,000 | 5,456,000 |
| Q4 2022 | 6,613,032 | 14,886,536 |
| Q1 2023 | 54,751,000 | 2,172,000 |